The surgery was very difficult due to the size of the tumor and its attachment to the intestines, bladder and other organs. It was not easy to remove the tumor because it could accidentally damage any ...

Plexiform fibromyxoma is a rare primary mesenchymal tumor of the gastrointestinal tract, first reported by Takahashi in 2007 and officially recognized as a subtype of gastric mesenchymal tumor by the ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, chemotherapy or radiation, the study found.

A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic gastrointestinal cancers than prior strategies, according to results of a ...

So, technologies such as intensity modulated radiation, stereotactic radiation, proton therapy, all of these are different things that we can say with very high confidence have drastically improved ...

Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours ...

A large-scale study provides the strongest evidence yet that a shorter, standard-dose course radiation treatment is just as effective as conventional radiotherapy for prostate cancer, without ...

KEYWORDS: Gastrointestinal Stromal Tumor, Radiotherapy, Resistance, Tyrosine Kinase Inhibitors JOURNAL NAME: Journal of Cancer Therapy, Vol.16 No.2, February 24, 2025 ABSTRACT: Purpose: ...

About IDRX-42 IDRX-42 is an investigational oral, small molecule KIT tyrosine kinase inhibitor in clinical development as a monotherapy for the treatment of gastrointestinal stromal tumors (GIST).

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these ...